Lipid Changes After Switch From TDF to TAF in the OPERA Cohort: LDL Cholesterol and Triglycerides

BACKGROUND: Increases in lipids have been observed in people with HIV (PWH) switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF). We assessed changes in low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) following a switch from TDF to TAF. METHODS: Adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallon, Patrick W G, Brunet, Laurence, Fusco, Jennifer S, Prajapati, Girish, Beyer, Andrew, Fusco, Gregory P, Wohlfeiler, Michael B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753026/
https://www.ncbi.nlm.nih.gov/pubmed/35028335
http://dx.doi.org/10.1093/ofid/ofab621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753026/
https://www.ncbi.nlm.nih.gov/pubmed/35028335
http://dx.doi.org/10.1093/ofid/ofab621

Ejemplares similares